Innovative Medicines Initiative Consultation on ATMPs
The Innovative Medicines Initiative (IMI) has issued a Consultation Paper on facilitating the translation of advanced therapies to patients in Europe. Against the background of growing research into Advanced Therapy Medicinal Products (ATMPs) IMI has developed a concept paper which aims to identify the potential of IMI as a platform for enhancing ATMP research and development.
Contributors who wish to submit comments on the concept paper are encouraged to consider in particular the following questions:
- Have the key challenges that can be addressed through collaborative, public-private initiatives been properly identified?
- Which of the proposed potential initiatives should be prioritised?
- Are any areas missing?
- What are the key European or national initiatives that IMI shall synergise with?
Deadline for submitting comments is 25 July 2016. Comments on the concept paper should be addressed by e-mail to consultations@imi.europa.eu.
